FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

24059711000001105: Umeclidinium bromide (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2015. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    78548901000001112 Umeclidinium bromide (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    78549001000001119 Umeclidinium bromide en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Umeclidinium bromide Is a Bronchodilator false Inferred relationship Existential restriction modifier
    Umeclidinium bromide Is a Substance with muscarinic receptor antagonist mechanism of action false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler Has specific active ingredient False Umeclidinium bromide Inferred relationship Existential restriction modifier
    Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) Has specific active ingredient False Umeclidinium bromide Inferred relationship Existential restriction modifier
    Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose Has specific active ingredient False Umeclidinium bromide Inferred relationship Existential restriction modifier
    Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose Has specific active ingredient False Umeclidinium bromide Inferred relationship Existential restriction modifier
    Umeclidinium bromide 65micrograms/dose dry powder inhaler Has specific active ingredient False Umeclidinium bromide Inferred relationship Existential restriction modifier
    Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) Has specific active ingredient False Umeclidinium bromide Inferred relationship Existential restriction modifier
    Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose Has specific active ingredient False Umeclidinium bromide Inferred relationship Existential restriction modifier
    Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose Has specific active ingredient False Umeclidinium bromide Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start